Nontuberculous Mycobacteria
|
|
- Wendy Ferguson
- 5 years ago
- Views:
Transcription
1 Nontuberculous Mycobacteria Epidemiology and Clinical Management Kevin L. Winthrop, MD, MPH Associate Professor, Divisions of Infectious Diseases, Public Health and Preventive Medicine Oregon Health & Science University Disclosures NTM Research funding Insmed NIH American Lung Association NTMir Nontuberculous Mycobacterium (NTM) MOTT Environmental organisms Soil, lakes, rivers Municipal water systems (yes, including your tap at home) Biofilm where water flows Live with amoeba, legionella, others 1
2 Nontuberculous Mycobacterium (NTM) Slow growers MAC, M. kansasii, M. marinum, M. xenopi Rapid growers (RGM) M. abscessus, M. chelonae, M. fortuitum 100+ species and growing 16s rdna gene sequencing Too many PhD candidates My favorite Proposed name: M. jacuzzii Surgical outbreak of skin infections 15 cases following breast augmentation Linked to one surgeon Cultures Surgeon s hair, face, eyebrows, nose, ears, and groin Surgeon s home jacuzzi All grew identical NTM isolates similar to M. smegmatis Rahav et al. CID 2006 Environment? Host? Killer showerheads? Related to publication by Feazel et al: Opportunistic pathogens enriched in showerhead biofilms. PNAS 2009: 38:
3 Pulmonary NTM? 16,810 NTM Disease Manifestations (Larger image on next page) Henkle E, et al. (abstract) ATS % of NTM disease is pulmonary 3
4 NTM Disease Manifestations Henkle E, et al. (abstract) ATS % of NTM disease is pulmonary
5 Pulmonary NTM Most common in US M. avium complex (MAC), M. kansasii, M. abscessus 2007 ATS/IDSA diagnostic criteria Patient with radiographic evidence of disease and pulmonary symptoms AND At least 2 sputum cultures positive, or One BAL or tissue specimen with positive culture, or Tissue with granulomatous histopathology in conjunction with positive culture (BAL or sputum) Griffith D et al. AJRCCM 2007 Marras T, et al. EID 2013 Increasing Rates with Age Prevots et al. AJRCCM
6 Distribution of Disease Hoefsloot W, et al Eur Respir J 2013
7 Distribution of Disease (Larger image on previous page) Hoefsloot W, et al Eur Respir J 2013 Two Disease Types Older male, smoker, COPD Apical cavitary or fibronodular disease More rapidly progressive Older female ( Lady-Windermere ) Scoliosis, thin, pectus deformities*, hypomastia, mitral valve prolapse Nodular and interstitial nodular infiltrate Bronchiectasis right middle lobe / lingula Bronchiolitis ( tree and bud ) on HRCT Slowly progressive *Iseman MD et al. Am Rev Respir Dis Disease Characteristics Differ by Sex Winthrop et al. AJRCCM
8 Risk Factors for Pulmonary NTM Primarily from case series level data Underlying lung architectural abnormalities Bronchiectasis, cystic fibrosis Alpha-one antitrypsin, emphysema Prior TB or other infection GERD with micro-aspiration Exposure/transmission information lacking Gardening? Hot tubs? 6
9 MAC Therapeutic Options Diagnosis decision to treat Observation vs. suppression vs. cure Treatment best defined for MAC Macrolide, rifampin, ethambutol Amikacin (parenteral or inhaled PRN) months (12 month culture negative) No macrolide monotherapy TIW okay if non-cavitary or not re-infection Griffith DG, et al. AJRCCM 2007 TIW vs. Daily Therapy Institutional-based series 180 pulmonary MAC patients Retrospective review of treatment outcomes 94% bronchiectatic and 98% non-cavitary 85% converted culture Similar between regimens (most switched to TIW) No difference between macrolides 48% relapses with positive culture post-treatment Wallace R, et al Chest 2014 (Larger image on next page) Wallace R, et al Chest
10 Wallace R, et al Chest 2014
11 Wallace R, et al Chest 2014
12 (Larger image on previous page) Wallace R, et al Chest 2014 M. kansasii M. Kansasii clinical presentation more like TB Thin-walled cavities and upper lobe disease common Treatment with INH, RIF, EMB TIW therapy probably fine 12 months culture negativity High treatment success rates (90%+) Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. ATS/CDC/IDSA AJRCCM 2007 Rapidly Progressive Disease 10 weeks while on therapy 8
13 M. abscessus Therapy Cure = rare (often treat off and on forever) More rapidly progressive or relentless than MAC 3-4 drugs for months 4-6 months induction phase suppressive strategy thereafter Rotational parenteral based regimen Parenteral Drugs Limited antibiotic options based upon susceptibility testing Parenteral agents Tigecycline 50mg daily Cefoxitin 2gm TID, Imipenam mg BID Amikacin 10mg/kg TIW M. abscessus Oral antibiotics---also very limited options Rarely macrolides Clofazimine Rarely moxifloxacin/ciprofloxacin Rarely linezolid Surgery for limited disease Jarand et al. CID
14 Erythromycin Methylase Gene erm(41) Koh et al. AJRCCM 2011
15 Erythromycin Methylase Gene erm(41) (Larger image on previous page) Koh et al. AJRCCM 2011 M. Abscessus (massiliense) Person-to-Person Transmission Repetitive unit-sequence based polymerase chain reaction Aitken ML, et al Am J Respir Crit Care Med 2012 Pulmonary Hygiene 10
16 Extrapulmonary NTM Immunocompetent settings Most infections occur 1-6 weeks after contact with contaminated water Nail salon, trauma, surgical or injection procedures, fishtank or other acquatic exposure Rapid or slow growing NTM Pediatric lymphadenitis Males > females, age 1-2 years old Children under 5 years NTM > TB 11
17 M. chelonae post plastic surgery M. marinum---fishtank granuloma Treatment Macrolides, sulfonamides, doxycycline, rifampin, ethambutol. Treat with 2 agents X 3-4 months. Surgical debridement if necessary. 12
18 13
19 IMID Biologic Therapies TNF- inhibition Infliximab, adalimumab, golimumab, certolizumab (monoclonal antibodies) Etanercept (soluble p75 receptor) Other Biologics CD4 co-stimulation modulator: abatacept B-cell (CD20+) antibody: rituximab Anti-IL-6 receptor antibody: tocilizumab Anti- IL12/IL23 antibody: ustekinumab Small molecules: tofacitinib Winthrop KL et al. Ann Rheum Dis 2013; Winthrop KL Nat Rheum Rev
20 Acknowledgements Close colleagues and friends at variety of institutions including: NJMC Mayo UT Tyler NIH Univ. Ontario U Florida CDC ATS/IDSA Cystic Fibrosis Registry (Larger image on next page) Nested case-control study Incident positive AFB culture in 2011 Controls with negative cultures 2010 and 2011 Binder A, et al American J of Clin Microbiology 2013 Chronic Macrolide Use Protective Against NTM (Larger image on next page) Binder A, et al American J of Clin Microbiology
21 Cystic Fibrosis Registry Nested case-control study Incident positive AFB culture in 2011 Controls with negative cultures 2010 and 2011 Binder A, et al American J of Clin Microbiology 2013
22 Chronic Macrolide Use Protective Against NTM Binder A, et al American J of Clin Microbiology 2013
2018 Vindico Medical Education. Non-tuberculous Mycobacteria: Circumventing Difficulties in Diagnosis and Treatment
Activity presentations are considered intellectual property. These slides may not be published or posted online without permission from Vindico Medical Education (cme@vindicocme.com). Please be respectful
More informationTB Intensive San Antonio, Texas August 7-10, 2012
TB Intensive San Antonio, Texas August 7-10, 2012 Nontuberculosis Mycobacterial Lung Disease David Griffith, MD August 8, 2012 David Griffith, MD has the following disclosures to make: No conflict of interests
More informationPulmonary Non Tuberculous Mycobacteria Infections
Non Tuberculous Mycobacteria Pulmonary Non Tuberculous Mycobacteria Infections Jorge Murillo, MD, FIDSA, FACP Associate Professor at FIU Herbert Wertheim College of Medicine Infectious Disease Consultant
More informationNontuberculous Mycobacterial Lung Disease
Non-TB Mycobacterial Disease Jeffrey P. Kanne, MD Nontuberculous Mycobacterial Lung Disease Jeffrey P. Kanne, M.D. Consultant Disclosures Perceptive Informatics Royalties (book author) Amirsys, Inc. Wolters
More informationHow Do I Manage Nontuberculous Mycobacterial (NTM) Lung Disease Patients?
How Do I Manage Nontuberculous Mycobacterial (NTM) Lung Disease Patients? David E. Griffith, M.D. Professor of Medicine University of Texas Health Science Center, Tyler Potential COI Statement I was a
More informationTB Intensive Houston, Texas October 15-17, 2013
TB Intensive Houston, Texas October 15-17, 2013 Nontuberculous Mycobacterial Lung Disease David Griffith, MD October 15, 2013 David Griffith, MD has the following disclosures to make: No conflict of interests
More informationNTM AND BRONCHIECTASIS (BXSIS): THE CHICKEN AND THE EGG
REMINGTON WINTER COURSE IN ID VAIL, CO FEBRUARY, 2010 NONTUBERCULOSIS MYCOBACTERIA AND BRONCHIECTASIS: Revised 1/28/10 10:31 AM- CQ MICHAEL D. ISEMAN, MD OR In some cases NTMs invade pre-existing BXSIS
More informationSlowly Growing Nontuberculous Mycobacterial Infections
Slowly Growing Nontuberculous Mycobacterial Infections Charles L. Daley, MD National Jewish Health University of Colorado, Denver Disclosures Advisory Board Horizon, Johnson and Johnson, Otsuka and Spero
More informationShannon Kasperbauer, M.D. National Jewish Health University of Colorado Health Sciences Center. Property of Presenter. Not for Reproduction
Shannon Kasperbauer, M.D. National Jewish Health University of Colorado Health Sciences Center Consultant: Johnson and Johnson Speaker/consultant: Insmed Examine characteristics of the RGM Define the main
More informationDiagnostic Evaluation of NTM and Bronchiectasis
Division of Pulmonary, Critical Care and Sleep Medicine Diagnostic Evaluation of NTM and Bronchiectasis Ashwin Basavaraj, MD, FCCP NTM patient education program November 9, 2016 Involves a combination
More informationNontuberculous Mycobacteria (NTM)
Nontuberculous Mycobacteria (NTM) Bacteria, like plants and animals, have been classified into similar groups. The groups are called "families." One such family of bacteria is known as the Mycobacteriaceae.
More informationCanadian Tuberculosis Standards
Canadian Tuberculosis Standards 7 th Edition Chapter 11: Nontuberculous Mycobacteria To promote and protect the health of Canadians through leadership, partnership, innovation and action in public health.
More informationMycobacteriosisok. Somoskövi Ákos
Mycobacteriosisok Somoskövi Ákos Phylogenetic position of the MTBC and NTM within the genus Mycobacteria Gutierrez and Somoskovi 2014 Encyclopedia of Human Biology Increased identification of NTMs Plethora
More informationDOWNLOAD OR READ : NONTUBERCULOUS MYCOBACTERIA NTM PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : NONTUBERCULOUS MYCOBACTERIA NTM PDF EBOOK EPUB MOBI Page 1 Page 2 nontuberculous mycobacteria ntm nontuberculous mycobacteria ntm pdf nontuberculous mycobacteria ntm patients and those
More informationNON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS ISOLATED FROM BIRMINGHAM HEARTLANDS HOSPITAL: A CASE NOTES REVIEW.
NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS ISOLATED FROM BIRMINGHAM HEARTLANDS HOSPITAL: A CASE NOTES REVIEW. K. Clay 1, K. Bhatt 1, D. Burns 1, J. Evans 2, S. Gardiner 2, EG. Smith 2, P. Hawkey 2,
More informationNontuberculous Mycobacteria: Ubiquitous Environmental Pathogens for Predisposed Hosts
Nontuberculous Mycobacteria: Ubiquitous Environmental Pathogens for Predisposed Hosts History, Epidemiology, Spectrum of Disease Diagnosis, Treatment and Predictors of Treatment Outcome James L. Cook,
More informationThe Epidemiology of NTM
The Epidemiology of NTM Jennifer Adjemian, PhD Deputy Chief, Epidemiology Unit Commander, US Public Health Service National Institute of Allergy and Infectious Diseases National Institutes of Health Presentation
More informationBronchiectasis and Nontuberculous Mycobacterial Disease
Bronchiectasis and Nontuberculous Mycobacterial Disease David E. Griffith, MD a, *, Timothy R. Aksamit, MD b KEYWORDS Nontuberculous mycobacteria Bronchiectasis Mycobacterium avium complex Mycobacterium
More informationNontuberculous Mycobacteria (NTM) in Patients with Cystic Fibrosis
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/cystic-fibrosis-in-focus/nontuberculous-mycobacteria-ntm-in-patientswith-cystic-fibrosis/8337/
More informationEpidemiology of NTM Lung Disease
Epidemiology of NTM Lung Disease NTM Lecture Series for Providers National Jewish Health Denver, CO October 19-20, 2017 Ted Marras, MD FRCPC MSc Toronto Western Hospital / University Health Network Disclosures
More informationInfection With the Mycobacterium avium Complex in Patients Without Predisposing Conditons A Case Report and Literature Review
BJID 2005; 9 (April) 173 Infection With the Mycobacterium avium Complex in Patients Without Predisposing Conditons A Case Report and Literature Review Andrea Barral Martins 1, Eliana Dias Matos 2,3 and
More informationCardiovascular Center Grand Rounds. December 15, 2016
Cardiovascular Center Grand Rounds December 15, 2016 Agenda Overview of Heater-Cooler Device Issue NTM Infection Incidence Chronology of Events and Communications Risk Management Implications Q&A NTM Grand
More informationNTM Lecture Series. Challenging Cases: Part 1. Property of Presenter
NTM Lecture Series Challenging Cases: Part 1 Dr. Wendi Kay Drummond DO, MPH Assistant Professor of Medicine Division of Mycobacterial and Infectious Diseases Department of Medicine September 27, 2018 Disclosures
More informationTuberculosis and Biologic Therapies: Risk and Prevention
Tuberculosis and Biologic Therapies: Risk and Prevention Kevin L. Winthrop, MD, MPH Associate Professor, Divisions of Infectious Diseases, Public Health and Preventive Medicine Oregon Health & Science
More informationDiagnosis and Treatment of Nontuberculous Mycobacterial Pulmonary Diseases
Diagnosis and Treatment of Nontuberculous Mycobacterial Pulmonary Diseases Jae Joon Yim, M.D. Sung Koo Han, M.D. Division of Pulmonary and Critical Care Medicine Department of Internal Medicine Seoul National
More informationClarithromycin-resistant Mycobacterium Shinjukuense Lung Disease: Case Report and Literature Review
Showa Univ J Med Sci 28 4, 373 377, December 2016 Case Report Clarithromycin-resistant Mycobacterium Shinjukuense Lung Disease: Case Report and Literature Review Makoto HAYASHI 1, Satoshi MATSUKURA 1,
More informationCHAPTER 3: DEFINITION OF TERMS
CHAPTER 3: DEFINITION OF TERMS NOTE: TB bacteria is used in place of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex in most of the definitions presented here. 3.1 Acid-fast bacteria
More informationCommunicable Disease Control Manual Chapter 4: Tuberculosis
Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual Definitions Page 1 2.0 DEFINITIONS Many of the definitions that follow are taken from
More informationStandardized Case Definition for Extrapulmonary Nontuberculous Mycobacteria Infections
Operational Guidance for Position Statement 17 ID 07: Standardized Case Definition for Extrapulmonary Nontuberculous Mycobacteria Infections Submission Date: April 28, 2017 Committee: Infectious Disease
More informationPeritoneal dialysis associated peritonitis secondary to Mycobacterium fortuitum
Case Reports Peritoneal dialysis associated peritonitis secondary to Mycobacterium fortuitum Paula McKenzie MD, David Sotello MD, Kunal Parekh MD, Kristen Fuhrmann PharmD, Richard Winn MD Abstract We report
More informationNovel Therapies for NTM
NTM Lecture Series for Providers Novel Therapies for NTM Kenneth N Olivier, MD, MPH Laboratory of Chronic Airway Infection Chief, Pulmonary Branch/DIR October 20, 2017 Disclosures Past: Cooperative Research
More informationNontuberculous mycobacterial infections
Chapter 8 Nontuberculous mycobacterial infections C.L. Daley Summary Nontuberculous mycobacteria (NTM) represent a large group of bacteria that have been isolated from environmental sources. When NTM are
More informationTuberculosis in Non-HIV Infected Immunosuppresed Hosts. TNFα inhibitors and beyond
Tuberculosis in Non-HIV Infected Immunosuppresed Hosts TNFα inhibitors and beyond David E. Griffith, MD Assistant Medical Director Heartland National TB Center Professor of Medicine University of Texas
More informationImplication of species change of Nontuberculous Mycobacteria during or after treatment
Lee et al. BMC Pulmonary Medicine (2017) 17:213 DOI 10.1186/s12890-017-0539-7 RESEARCH ARTICLE Open Access Implication of species change of Nontuberculous Mycobacteria during or after Jong Sik Lee 1, Jong
More informationBest Practices for Pulmonary Nontuberculous Mycobacteria
Best Practices for Pulmonary Nontuberculous Mycobacteria June 2017 Public Health Ontario Public Health Ontario is a Crown corporation dedicated to protecting and promoting the health of all Ontarians and
More informationFirst described as a respiratory tract pathogen. Clinical relevance of Mycobacterium malmoense isolation in the Netherlands
Eur Respir J 2009; 34: 926 931 DOI: 10.1183/09031936.00039009 CopyrightßERS Journals Ltd 2009 Clinical relevance of Mycobacterium malmoense isolation in the Netherlands W. Hoefsloot*, J. van Ingen*,#,
More informationMycobacterial Infections in HIV. H. Gene Stringer, Jr., MD Infectious Diseases Section Department of Medicine Morehouse School of Medicine
Mycobacterial Infections in HIV H. Gene Stringer, Jr., MD Infectious Diseases Section Department of Medicine Morehouse School of Medicine Learning Objectives List the most common mycobacterial infections
More informationHow To Assess Severity and Prognosis
How To Assess Severity and Prognosis Gregory Tino, M.D. Chief, Department of Medicine Penn Presbyterian Medical Center Associate Professor of Medicine Perelman School of Medicine at the University of Pennsylvania
More informationOriginal Article Tree-in-bud pattern of chest CT images for diagnosis of Mycobacterium abscesses
Int J Clin Exp Med 2015;8(10):18705-18712 www.ijcem.com /ISSN:1940-5901/IJCEM0013538 Original Article Tree-in-bud pattern of chest CT images for diagnosis of Mycobacterium Haiqing Chu 1, Bing Li 1, Lan
More informationWSLH Testing and Surveillance Updates
WSLH Testing and Surveillance Updates Wisconsin Mycobacteriology Laboratory Network annual conference November 4, 2015, Madison, WI Updates Outline Collection and Transport Smear and Culture Nucleic Acid
More informationGeographical distribution and clinical relevance of nontuberculous mycobacteria in Croatia
Geographical distribution and clinical relevance of nontuberculous mycobacteria in Croatia M. Jankovic 1, M. Samarzija 1, I. Sabol 2, M. Jakopovic 1, V. Katalinic Jankovic 3, LJ. Zmak 3, B. Ticac 4, A.
More informationNontuberculous Mycobacterial Pulmonary Disease
Pulmonary Disease Board Review Manual Statement of Editorial Purpose The Hospital Physician Pulmonary Disease Board Review Manual is a peer-reviewed study guide for fellows and practicing physicians preparing
More informationProperty of Presenter. Not for Reproduction EXTRAPULMONARY NTM INFECTIONS
EXTRAPULMONARY NTM INFECTIONS Shannon Kasperbauer, MD National Jewish Health University of Colorado Health Sciences Center DISCLOSURE Consultant: Johnson and Johnson Invited Speaker: Insmed OBJECTIVES
More informationHyun Su Kim, MD Kyung Soo Lee, MD Won-Jung Koh, MD Kyeongman Jeon, MD Eun Ju Lee, MD Hee Kang, MD Joonghyun Ahn, PhD. Purpose: Materials and Methods:
Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Original Research
More informationDIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE
DIAGNOSIS AND MEDICAL MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH Assistant Professor University of Texas Health Science Center Staff Physician, Texas Center for Infectious Diseases TB Nurse Case
More informationTUBERCULOSIS. Pathogenesis and Transmission
TUBERCULOSIS Pathogenesis and Transmission TUBERCULOSIS Pathogenesis and Transmission Infection to Disease Diagnostic & Isolation Updates Treatment Updates Pathogenesis Droplet nuclei of 5µm or less are
More informationhas the following disclosures to make:
CLINICAL DIAGNOSIS AND MANAGEMENT OF TB DISEASE Annie Kizilbash MD, MPH September 22, 2015 TB Nurse Case Management September 22 24, 2015 San Antonio. TX EXCELLENCE EXPERTISE INNOVATION Annie Kizilbash
More informationNontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not?
NEW MICROBIOLOGICA, 33, 399-403, 2010 Nontuberculous mycobacteria isolated from pulmonary specimens between 2004 and 2009: causative agent or not? Can Bicmen 1, Meral Coskun 1, Ayriz T. Gunduz 1, Gunes
More informationNontuberculous Mycobacteria and Heater-Cooler Devices: A CDC Update
National Center for Emerging and Zoonotic Infectious Diseases Nontuberculous Mycobacteria and Heater-Cooler Devices: A CDC Update Kiran Perkins, MD, MPH Medical Officer Division of Healthcare Quality Promotion
More informationDiagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease
REVIEW Respiratory Diseases http://dx.doi.org/10.3346/jkms.2016.31.5.649 J Korean Med Sci 2016; 31: 649-659 Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease Yong-Soo Kwon 1 and Won-Jung
More informationTreatment of Tuberculosis
TB Intensive Tyler, Texas June 1-3, 2009 Treatment of Tuberculosis Barbara Seaworth, MD June 3, 2009 Treatment of Tuberculosis Barbara J Seaworth MD Medical Director Heartland National TB Center 1 Purpose
More informationOpportunistic Infections and Tuberculosis Risk Management
Opportunistic Infections and Tuberculosis Risk Management Kevin L. Winthrop, MD, MPH Associate Professor, Divisions of Infectious Diseases, Public Health, and Preventive Medicine Oregon Health & Science
More informationTreatment of Active Tuberculosis
Treatment of Active Tuberculosis Jeremy Clain, MD Pulmonary & Critical Care Medicine Mayo Clinic October 16, 2017 2014 MFMER slide-1 Disclosures No relevant financial relationships No conflicts of interest
More informationMycobacterium fortuitum,
2009 177 Mycobacterium fortuitum 1 1) 2) 3) 1) 1) 4) 4) 5) 2) 1) 1) 2) 3) 4) 5) 21 3 16 21 7 1 Mycobacterium fortuitum 1 39 BHI 2 Ziehl Neelsen M. fortuitum MIC CPFX 0.2 mg/ml, MINO 0.78 mg/ml, CAM 100
More informationNontuberculous Mycobacterial Pulmonary Diseases in Immunocompetent Patients
Nontuberculous Mycobacterial Pulmonary Diseases in Immunocompetent Patients Won-Jung Koh, MD 1 O Jung Kwon, MD 1 Kyung Soo Lee, MD 2 Nontuberculous mycobacterial (NTM) infections are an increasingly recognized
More informationKey words: azithromycin; bronchiectasis; clarithromycin; clofazimine; ethambutol; Mycobacterium avium
Treatment of Mycobacterium aviumintracellulare complex Lung Disease With a Macrolide, Ethambutol, and Clofazimine* Stephen K. Field, MD, CM, FCCP; Robert L. Cowie, MD, MSc Background: Mycobacterium avium-intracellulare
More informationRADIOLOGIC EVALUATION OF PULMONARY NTM INFECTION. Tilman Koelsch, MD National Jewish Health - Department of Radiology
Pr N op ot e fo rty rr o f ep Pr ro es du en ct te io r n RADIOLOGIC EVALUATION OF PULMONARY NTM INFECTION Tilman Koelsch, MD National Jewish Health - Department of Radiology Disclosures None Goals Identify
More informationTreatment of Mycobacterium avium Complex Pulmonary Disease
REVIEW https://doi.org/10.4046/trd.2018.0060 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2019;82:15-26 Treatment of Mycobacterium avium Complex Pulmonary Disease Yong-Soo Kwon, M.D. 1, Won-Jung
More informationNontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis
Respiratory Medicine (2009) 103, 1936e1940 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Nontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis
More informationDiagnosis and Medical Management of TB Disease. Quratulian Annie Kizilbash, MD, MPH March 17, 2015
Diagnosis and Medical Management of TB Disease Quratulian Annie Kizilbash, MD, MPH March 17, 2015 TB Nurse Case Management March 17 19, 2015 San Antonio, Texas EXCELLENCE EXPERTISE INNOVATION Quratulian
More informationAFB Identification Texas Approach
AFB Identification Texas Approach Ken Jost Texas Department of State Health Services 6th National Conference on Laboratory Aspects of TB June 21, 2010 DSHS-Austin TB Lab Customers & Samples Year 2009 175
More informationWhy are We Concerned with Non-Tuberculous Mycobacteria?
Why are We Concerned with Non-Tuberculous Mycobacteria? Wisconsin State Laboratory of Hygiene Julie Tans-Kersten, MS, BS-MT (ASCP) Tuberculosis Laboratory Program Coordinator Wisconsin State Laboratory
More informationTreatment of Tuberculosis, 2017
Treatment of Tuberculosis, 2017 Charles L. Daley, MD National Jewish Health University of Colorado Health Sciences Center Treatment of Tuberculosis Disclosures Advisory Board Horizon, Johnson and Johnson,
More informationRADIOLOGIC EVALUATION OF PULMONARY NTM INFECTION. Tilman Koelsch, MD National Jewish Health - Department of Radiology
Pr N op ot er fo ty r R of ep Pr ro es du en ct te io r n RADIOLOGIC EVALUATION OF PULMONARY NTM INFECTION Tilman Koelsch, MD National Jewish Health - Department of Radiology Disclosures No relevant financial
More informationMycobacterium abscessus Lung Disease in a Patient with Kartagener Syndrome
CASE REPORT http://dx.doi.org/10.4046/trd.2014.77.3.136 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2014;77:136-140 Mycobacterium abscessus Lung Disease in a Patient with Kartagener Syndrome
More informationNontuberculous Mycobacteria
Nontuberculous Mycobacteria When antibiotics are not enough a surgical approach John D. Mitchell, M.D. Davis Endowed Chair in Thoracic Surgery Professor and Chief Section of General Thoracic Surgery University
More informationGeneral Infectious Diseases
Contents General Infectious Diseases Atibordee Meesing, MD Division of infectious disease Department of Medicine Khon kaen University Tuberculosis (TB) Overview of Nontuberculous Mycobacterial (NTM) Infections
More informationMULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic
MULTIDRUG- RESISTANT TUBERCULOSIS Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic I have no relevant financial relationships. Discussion includes off label use of: amikacin
More informationConsolidations in Nodular Bronchiectatic Mycobacterium Avium Complex Lung Disease: Mycobacterium Avium Complex or Other Infection?
Original Article DOI 10.3349/ymj.2010.51.4.546 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 51(4):546-551, 2010 Consolidations in Nodular Bronchiectatic Mycobacterium Avium Complex Lung Disease: Mycobacterium
More informationDiagnosis of Pulmonary Tuberculosis and Nontuberculous Mycobacterial Lung Disease in Korea
REVIEW http://dx.doi.org/10.4046/trd.2014.77.1.1 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2014;77:1-5 Diagnosis of Pulmonary Tuberculosis and Nontuberculous Mycobacterial Lung Disease
More informationNon-tuberculous mycobacterial pulmonary infections
Clin Chest Med 23 (2002) 369 376 Non-tuberculous mycobacterial pulmonary infections Alimuddin I. Zumla PhD, FRCP a, *, John Grange, MD, MSc b a Centre for Infectious Diseases and International Health,
More informationTB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?
Those oral antibiotics are just not working! Inpatient Standards of Care & Discharge Planning S/He s in the Hospital: Now What Do I Do? Dana G. Kissner, MD TB Intensive Workshop, Lansing, MI 2012 Objectives:
More informationDiagnosis and Treatment of Tuberculosis, 2011
Diagnosis of TB Diagnosis and Treatment of Tuberculosis, 2011 Alfred Lardizabal, MD NJMS Global Tuberculosis Institute Diagnosis of TB, 2011 Diagnosis follows Suspicion When should we Think TB? Who is
More informationResearch Article Computed Tomography Findings of Pulmonary Mycobacterium simiae Infection
Hindawi Canadian Respiratory Journal Volume 2017, Article ID 6913564, 5 pages https://doi.org/10.1155/2017/6913564 Research Article Computed Tomography Findings of Pulmonary Mycobacterium simiae Infection
More informationRandomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung
ONLINE DATA SUPPLEMENT Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease Kenneth N. Olivier, David E. Griffith, Gina Eagle, John P. McGinnis II, Liza Micioni,
More informationDiagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015
Diagnosis & Medical Case Management of TB Disease Lisa Armitige, MD, PhD October 22, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE
More informationCLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease
CLINICAL DIAGNOSIS AND MANAGEMENT OF TB Disease Barbara J Seaworth MD Medical Director Heartland National TB Center Professor of Medicine University of Texas Health Center Tyler Barbara J Seaworth MD has
More informationCharacteristics of Mycobacterium
Mycobacterium Characteristics of Mycobacterium Very thin, rod shape. Culture: Aerobic, need high levels of oxygen to grow. Very slow in grow compared to other bacteria (colonies may be visible in up to
More informationSerodiagnosis of Mycobacterium avium complex pulmonary disease in the USA
ORIGINAL ARTICLE PULMONARY INFECTIONS Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA Seigo Kitada 1, Adrah Levin 2, Melissa Hiserote 3, Ron J. Harbeck 3, Chris A. Czaja 2,4,
More informationShah et al. BMC Infectious Diseases (2016) 16:195 DOI /s
Shah et al. BMC Infectious Diseases (2016) 16:195 DOI 10.1186/s12879-016-1521-3 RESEARCH ARTICLE Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria
More informationPediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017
Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017 TB Nurse Case Management September 12 14, 2017 EXCELLENCE EXPERTISE INNOVATION Lisa Y. Armitige, MD, PhD has the following disclosures
More informationManaging Complex TB Cases Diana M. Nilsen, MD, RN
Managing Complex TB Cases Diana M. Nilsen, MD, RN Director of Medical Affairs NYC Department of Health & Mental Hygiene Bureau of TB Control Case #1 You are managing a patient who was seen at a private
More informationInhaled Amikacin for Treatment of Refractory Pulmonary Nontuberculous Mycobacterial Disease
Inhaled Amikacin for Treatment of Refractory Pulmonary Nontuberculous Mycobacterial Disease Kenneth N. Olivier 1, Pamela A. Shaw 2, Tanya S. Glaser 1, Darshana Bhattacharyya 1, Michelle Fleshner 1, Carmen
More informationMycobacterium abscessus subsp abscessus lung disease: trouble ahead, trouble behind David E. Griffith
Published: 04 November 2014 2014 Faculty of 1000 Ltd Mycobacterium abscessus subsp abscessus lung disease: trouble ahead, trouble behind David E. Griffith Address: University of Texas Health Science Center,
More informationAntibiotic Treatment of Mycobacterium abscessus Lung Disease A Retrospective Analysis of 65 Patients
Antibiotic Treatment of Mycobacterium abscessus Lung Disease A Retrospective Analysis of 65 Patients Kyeongman Jeon 1, O Jung Kwon 1, Nam Yong Lee 2, Bum-Joon Kim 3, Yoon-Hoh Kook 3, Seung-Heon Lee 4,
More informationAdvanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014
Advanced Management of Patients with Tuberculosis Little Rock, Arkansas August 13 14, 2014 Tuberculosis Pathogenesis and Treatment of Latent TB Infection Lisa Armitige, MD, PhD August 13, 2014 Lisa Armitige,
More informationTuberculosis Pathogenesis
Tuberculosis Pathogenesis Renuka Khurana, MD, MPH May 12, 2015 TB for Community Providers May 12, 2015 Phoenix, Arizona EXCELLENCE EXPERTISE INNOVATION Renuka Khurana, MD, MPH has the following disclosures
More informationMycobacterial Infections: What the Primary Provider Should Know about Tuberculosis
Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening
More informationMycobacteriology William H. Benjamin, Jr.
Mycobacteriology William H. Benjamin, Jr. William H. Benjamin, PhD Department of Pathology UAB 1 Mycobacteria sp. Acid Fast Bacilli (AFB) Mycolic acids (C78-91) Waxes Obligate aerobes Slow growing days
More informationNTM Lecture Series. Challenging Cases: Part 2. Property of Presenter
NTM Lecture Series Challenging Cases: Part 2 Dr. Wendi Kay Drummond DO, MPH Assistant Professor of Medicine Division of Mycobacterial and Infectious Diseases Department of Medicine October 20, 2017 Disclosures
More informationWhen Can Isolation Be Discontinued?
When Can Isolation Be Discontinued? - It Depends on the Patient and the Setting. Masae Kawamura M.D. and Barbara Seaworth M.D. Texas: (800) TEX-LUNG New Jersey: 973-972-3270? HNTC Consultation Line California:
More informationMycobacterium paraffinicum causing symptomatic pulmonary infection. Austin W. Chan (1), Sarah Kabbani (2), Gerald Staton (3), Colleen S.
JCM Accepts, published online ahead of print on 22 January 2014 J. Clin. Microbiol. doi:10.1128/jcm.03107-13 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10
More informationTB Nurse Case Management San Antonio, Texas April 9-11, 2013
TB Nurse Case Management San Antonio, Texas April 9-11, 2013 TB / Dose Counting Rachel Munoz, RN. TB Nurse Case Manager/Nurse Consultant Austin/Travis County Health Department April 10, 2013 Rachel Munoz,
More informationLe micobatteriosi polmonari Maurizio Ferrarese ASST Grande Ospedale Metropolitano Niguarda - Villa Marelli USD Tisiologia Clinica e Preventiva Centro
Le micobatteriosi polmonari Maurizio Ferrarese ASST Grande Ospedale Metropolitano Niguarda - Villa Marelli USD Tisiologia Clinica e Preventiva Centro Regionale di Riferimento per la Tubercolosi Milano
More informationSuccessful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report
Namkoong et al. BMC Pulmonary Medicine (2015) 15:126 DOI 10.1186/s12890-015-0130-z CASE REPORT Open Access Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium
More informationTuberculosis and TNF Inhibitors
Tuberculosis and TNF Inhibitors Sundari Mase MD, MPH Medical Team Lead CDC/DTBE/FSEB January 18, 2011 Objectives Discuss the association between and epidemiology of TNF inhibitors and TB Discuss the challenges
More informationPrevalence of Gastroesophageal Reflux Disease in Patients With Nontuberculous Mycobacterial Lung Disease*
Original Research MYCOBACTERIAL DISEASE Prevalence of Gastroesophageal Reflux Disease in Patients With Nontuberculous Mycobacterial Lung Disease* Won-Jung Koh, MD; Jun Haeng Lee, MD; Yong Soo Kwon, MD;
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)
DERBYSHIRE JOINT AREA PRERIBING COMMITTEE (JAPC) Derbyshire commissioning guidance on biologic drugs f the treatment of Rheumatoid arthritis with methotrexate This algithm is a tool to aid the implementation
More informationTitle: Cefoxitin Continuous Infusion for Lung Infection Caused by M. abscessus group
AAC Accepts, published online ahead of print on 14 April 2014 Antimicrob. Agents Chemother. doi:10.1128/aac.02763-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 Title: Cefoxitin
More information